Palatin Technologies
PTN
#10926
Rank
A$16.17 M
Marketcap
A$9.08
Share price
9.81%
Change (1 day)
-53.64%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -A$9.22 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$12.88 Million. In 2025 the company made an earning of -A$13.94 Million, an increase over its 2024 earnings that were of -A$39.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$9.22 Million-33.84%
2025 -A$13.94 Million-64.29%
2024 -A$39.02 Million-16.9%
2023 -A$46.96 Million5.99%
2022 -A$44.31 Million-13.7%
2021 -A$51.34 Million33.25%
2020 -A$38.53 Million-172.11%
2019 A$53.42 M2352.33%
2018 A$2.17 M-94.13%
2017 A$37.12 M-154.92%
2016 -A$67.59 Million3.67%
2015 -A$65.2 Million878%
2014 -A$6.67 Million-72.64%
2013 -A$24.37 Million-33.11%
2012 -A$36.43 Million77.71%
2011 -A$20.5 Million
2003 -A$34.71 Million29.93%
2002 -A$26.72 Million36.18%
2001 -A$19.62 Million
1999 -A$16.29 Million6.04%
1998 -A$15.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.11 B-300,026.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.75 B-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.18 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$15.57 Million 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.35 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.20 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$42.71 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$80.35 Million 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA